Literature DB >> 31453774

Implementation of wide-scale pharmacogenetic testing in primary care.

Jordan Baye1,2,3, Aissa Aifaoui1, Russell A Wilke4,5, Roxana A Lupu4,5, John Savageau6, Britni Gapp6, Amanda Massmann1, Deidre Hahn2, Catherine Hajek1,5, April Schultz1,5.   

Abstract

The convergence of translational genomics and biomedical informatics has changed healthcare delivery. Institutional consortia have begun implementing lab testing and decision support for drug-gene interactions. Aggregate datasets are now revealing the impact of clinical decision support for drug-gene interactions. Given the pleiotropic nature of pharmacogenes, interdisciplinary teams and robust clinical decision support tools must exist within an informatics framework built to be flexible and capable of cross-talk between clinical specialties. Navigation of the challenges presented with the implementation of five steps to build a genetics program infrastructure requires the expertise of multiple healthcare professionals. Ultimately, this manuscript describes our efforts to place pharmacogenomics in the hands of the primary care provider integrating this information into a patient's healthcare over their lifetime.

Entities:  

Keywords:  clinical decision support; education; implementation; inter-professional; pharmacogenetics; pharmacogenomics; primary care

Mesh:

Year:  2019        PMID: 31453774     DOI: 10.2217/pgs-2019-0043

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  10 in total

Review 1.  Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.

Authors:  Cyrine E Haidar; Kristine R Crews; James M Hoffman; Mary V Relling; Kelly E Caudle
Journal:  Annu Rev Genomics Hum Genet       Date:  2022-05-10       Impact factor: 9.340

Review 2.  Pharmacogenomics education, research and clinical implementation in the state of Minnesota.

Authors:  Jeffrey R Bishop; R Stephanie Huang; Jacob T Brown; Pawel Mroz; Steven G Johnson; Josiah D Allen; Suzette J Bielinski; Julie England; Joel F Farley; David Gregornik; Jyothsna Giri; Christine Kroger; Susie E Long; Tiana Luczak; Erin J McGonagle; Sisi Ma; Eric T Matey; Pinar K Mandic; Ann M Moyer; Wayne T Nicholson; Natasha Petry; Pamala A Pawloski; Allyson Schlichte; Stephen W Schondelmeyer; Randall D Seifert; Marilyn K Speedie; David Stenehjem; Robert J Straka; Jason Wachtl; Stephen C Waring; Brian Van Ness; Heather A Zierhut; Constantin Aliferis; Susan M Wolf; Catherine A McCarty; Pamala A Jacobson
Journal:  Pharmacogenomics       Date:  2021-06-17       Impact factor: 2.638

Review 3.  Moving Pharmacogenetics Into Practice: It's All About the Evidence!

Authors:  Jasmine A Luzum; Natasha Petry; Annette K Taylor; Sara L Van Driest; Henry M Dunnenberger; Larisa H Cavallari
Journal:  Clin Pharmacol Ther       Date:  2021-07-07       Impact factor: 6.903

Review 4.  Engaging pharmacogenomics in pain management and opioid selection.

Authors:  David R Bright; Natasha Petry; Eric Roath; Tyler Gibb
Journal:  Pharmacogenomics       Date:  2021-09-15       Impact factor: 2.638

5.  Using Personal Genomic Data within Primary Care: A Bioinformatics Approach to Pharmacogenomics.

Authors:  Rick Overkleeft; Judith Tommel; Andrea W M Evers; Johan T den Dunnen; Marco Roos; Marie-José Hoefmans; Walter E Schrader; Jesse J Swen; Mattijs E Numans; Elisa J F Houwink
Journal:  Genes (Basel)       Date:  2020-11-30       Impact factor: 4.096

6.  Precision Population Medicine in Primary Care: The Sanford Chip Experience.

Authors:  Kurt D Christensen; Megan Bell; Carrie L B Zawatsky; Lauren N Galbraith; Robert C Green; Allison M Hutchinson; Leila Jamal; Jessica L LeBlanc; Jennifer R Leonhard; Michelle Moore; Lisa Mullineaux; Natasha Petry; Dylan M Platt; Sherin Shaaban; April Schultz; Bethany D Tucker; Joel Van Heukelom; Elizabeth Wheeler; Emilie S Zoltick; Catherine Hajek
Journal:  Front Genet       Date:  2021-03-12       Impact factor: 4.599

7.  Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.

Authors:  Jason L Vassy; J Michael Gaziano; Robert C Green; Ryan E Ferguson; Sanjay Advani; Stephen J Miller; Sojeong Chun; Anthony K Hage; Soo-Ji Seo; Nilla Majahalme; Lauren MacMullen; Andrew J Zimolzak; Charles A Brunette
Journal:  JAMA Netw Open       Date:  2020-12-01

8.  SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care.

Authors:  Deepak Voora; Jordan Baye; Adam McDermaid; Smitha Narayana Gowda; Russell A Wilke; Anna Nicole Myrmoe; Catherine Hajek; Eric A Larson
Journal:  Clin Pharmacol Ther       Date:  2022-02-05       Impact factor: 6.903

9.  Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative Survey.

Authors:  Megan C Roberts; Lisa P Spees; Andrew N Freedman; William M P Klein; Irene Prabhu Das; Eboneé N Butler; Janet S de Moor
Journal:  JCO Precis Oncol       Date:  2021-04-22

Review 10.  Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example.

Authors:  David F Kisor; Natasha J Petry; David R Bright
Journal:  Pharmgenomics Pers Med       Date:  2021-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.